Showing 1 - 9 results of 9 for search 'Michael L Johnson', query time: 0.04s Refine Results
  1. 1
    Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

    Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 by Tyler J. Varisco, Michael L. Johnson, Douglas Thornton

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Potential factors affecting survival differ by run-timing and location: linear mixed-effects models of Pacific salmonids (Oncorhynchus spp.) in the Klamath River, California.

    Potential factors affecting survival differ by run-timing and location: linear mixed-effects models of Pacific salmonids (Oncorhynchus spp.) in the Klamath River, California. by Rebecca M Quiñones, Marcel Holyoak, Michael L Johnson, Peter B Moyle

    Published 2014-01-01
    Get full text
    Article
  3. 3
    <em><strong>Erratum dated 2014 June 25</strong></em>: Fate and Transport of Three Pharmaceuticals in the Sacramento-San Joaquin Delta

    <em><strong>Erratum dated 2014 June 25</strong></em>: Fate and Transport of Three Pharmaceuticals in the Sacramento-San Joaquin Delta by Minta M. Schaefer, Laura A. Doyle, William E. Fleenor, Michael L. Johnson

    Published 2013-06-01
    Get full text
    Article
  4. 4
    Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

    Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data by Manvi Sharma, Aisha Vadhariya, Michael L. Johnson, Zachary A. Marcum, Holly M. Holmes

    Published 2018-04-01
    Get full text
    Article
  5. 5
    Noninvasive methods for estradiol recovery from infant fecal samples

    Noninvasive methods for estradiol recovery from infant fecal samples by Amanda L Thompson, Amanda L Thompson, Patricia L Whitten, Michael L Johnson, Michelle L Lampl

    Published 2010-11-01
    Get full text
    Article
  6. 6
    Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis

    Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis by Yinan Huang, Satabdi Chatterjee, Sandeep K. Agarwal, Hua Chen, Michael L. Johnson, Rajender R. Aparasu

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis

    Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis by Jagadeswara Rao Earla, George J. Hutton, J. Douglas Thornton, Hua Chen, Michael L. Johnson, Rajender R. Aparasu

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

    Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study by Matthew A. Wanat, Xin Wang, Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Marc L. Fleming, Susan M. Abughosh

    Published 2019-10-01
    Get full text
    Article
  9. 9
    Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients

    Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients by Mantasha Tabassum, Soumya G. Chikermane, Camille Johnson, Noor M. Abdulkareem, Elisabeth M. Wang, Michael L. Johnson, Meghana V. Trivedi

    Published 2024-03-01
    Get full text
    Article

Search Tools: